(Q61918014)

English

Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Effects of Insulin Detemir Versus Regular Insulin (Actrapid) on Hormonal Counterregulation, Cognitive Function and Symptom Perception During Hypoglycemia (English)

0 references

0 references

0 references

0 references

Counterregulation by the Coreceptors CD19 and CD22 of MAP Kinase Activation by Membrane Immunoglobulin

0 references

insulin therapy

0 references

start time

March 2006

0 references

number of participants

12

0 references

research intervention

insulin detemir

0 references

clinical trial phase

phase IV clinical trial

0 references

research subject recruitment status

terminated

0 references

minimum age

18 year

0 references

maximum age

50 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00490893

0 references

(Q61918014)

Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)